Center-Authored Papers

Filters: Author is Urba, Susan G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Taxoids
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
September 2013
Swarm RA, Abernethy AP, Anghelescu DL, Benedetti C, Buga S, Cleeland C, Deleon-Casasola OA, Eilers JG, Ferrell B, Green M et al..  2013.  Adult cancer pain.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(8):992-1022. Abstract
Radiotherapy, Adjuvant
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
Pyridines
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Public Health Sciences Division
Mehta S, Moon J, Hashmi M, LeBlanc M, Huang CH, Rinehart E, Wolf GT, Urba SG, Banerjee SK, Williamson S.  2013.  Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420.. Oncology reports. 29(6):2095-100. Abstract
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
November 2012
Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, Deshields TL, Dexter E, Dy SM, Knight SJ et al..  2012.  Palliative care.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(10):1284-309. Abstract
Neoplasm Metastasis
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Middle Aged
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
May 2014
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH et al..  2014.  Survivorship: sleep disorders, version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(5):630-42. Abstract
May 2013
Mehta S, Moon J, Hashmi M, LeBlanc M, Huang CH, Rinehart E, Wolf GT, Urba SG, Banerjee SK, Williamson S.  2013.  Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420.. Oncology reports. 29(6):2095-100. Abstract
May 2012
Ettinger DS, Armstrong DK, Barbour S, Berger MJ, Bierman PJ, Bradbury B, Ellis G, Kirkegaard S, Kloth DD, Kris MG et al..  2012.  Antiemesis.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(4):456-85.
March 2014
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A et al..  2014.  Survivorship: sexual dysfunction (female), version 1.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(2):184-92. Abstract
Male
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
July 2014
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH et al..  2014.  Survivorship: fatigue, version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(6):876-87. Abstract
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH et al..  2014.  Survivorship: cognitive function, version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(7):976-86. Abstract
Humans
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Head and Neck Neoplasms
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
Fluorouracil
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract
Female
Williamson SK, Moon J, Huang CH, Guaglianone PP, LeBlanc M, Wolf GT, Urba SG.  2010.  Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(20):3330-5. Abstract
Adelstein DJ, Moon J, Hanna E, Giri SPG, Mills GM, Wolf GT, Urba SG.  2010.  Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II tria. Head & neck. 32(2):221-8. Abstract